Page last updated: 2024-08-26

22-hydroxycholesterol and resiquimod

22-hydroxycholesterol has been researched along with resiquimod in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asgarova, A; Biichlé, S; Ceroi, A; Delettre, FA; Duperrier, A; Gauthier, T; Lagrost, L; Marotel, C; Masson, D; Mourey, G; Perruche, S; Saas, P1

Other Studies

1 other study(ies) available for 22-hydroxycholesterol and resiquimod

ArticleYear
The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation.
    Haematologica, 2016, Volume: 101, Issue:3

    Topics: Angiogenic Proteins; ATP Binding Cassette Transporter 1; Benzoates; Benzylamines; Blood Platelets; Cell-Derived Microparticles; Dendritic Cells; Endothelial Cells; Gene Expression Regulation; Humans; Hydrocarbons, Fluorinated; Hydroxycholesterols; Imidazoles; Immunity, Innate; Liver X Receptors; NF-kappa B; Oligodeoxyribonucleotides; Phenylenediamines; Primary Cell Culture; Receptors, G-Protein-Coupled; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Sulfonamides; Toll-Like Receptor 7; Tumor Necrosis Factor-alpha

2016